Alzheimer's disease poses significant management challenges and financial burdens. It is a progressive brain disorder that currently afflicts over 5 million Americans, with projected rates increasing to over 16 million by 2050. Total annual costs of care exceed $100 billion currently. While there is no cure, addressing preventable risk factors like hypertension through lifestyle changes may help delay or prevent the onset of Alzheimer's disease, potentially reducing healthcare costs. Non-invasive screening methods can help detect risks early. Further research on interventions like dementia care mapping shows promise for improving patient outcomes while maintaining cost neutrality.
The goal of this webinar was to help healthcare professionals improve care coordination for patients with advanced illness and to reduce hospital readmissions and length of stay.
The goal of this webinar is to help hospice and healthcare professionals understand the history, philosophy and practice of hospice care and palliative care, including common myths and misconceptions, common diagnoses for hospice referrals, identification of hospice-eligible patients, reimbursement for hospice services, and the benefits of advance care planning and early referrals.
The goal of this webinar was to help hospice and healthcare professionals understand the history, philosophy, and practice of hospice and palliative care, including common misconceptions, typical diagnoses for hospice referrals, identification of hospice-eligible patients, reimbursement for hospice services, and the
benefits of advance care planning and early referrals.
The goal of this webinar was to help healthcare professionals improve care coordination for patients with advanced illness and to reduce hospital readmissions and length of stay.
The goal of this webinar is to help hospice and healthcare professionals understand the history, philosophy and practice of hospice care and palliative care, including common myths and misconceptions, common diagnoses for hospice referrals, identification of hospice-eligible patients, reimbursement for hospice services, and the benefits of advance care planning and early referrals.
The goal of this webinar was to help hospice and healthcare professionals understand the history, philosophy, and practice of hospice and palliative care, including common misconceptions, typical diagnoses for hospice referrals, identification of hospice-eligible patients, reimbursement for hospice services, and the
benefits of advance care planning and early referrals.
April 18, 2018
Decision aids can be highly-effective tools to promote shared decision making and support patients in becoming engaged participants in their healthcare. Join us for the first-ever convening with leaders behind a Washington experiment in certifying decision aids, as state officials, health systems, and on-the-ground implementation experts share lessons learned and discuss policy recommendations for national or statewide approaches to decision aid certification.
For more information, visit our website at: http://petrieflom.law.harvard.edu/events/details/decision-aids-for-patients-with-serious-illness
Platforms for Chronic Disease Management at Health 2.0DrBonnie360
There are approximately 117M Americans living with chronic disease. Chronic medical conditions took 85% of all healthcare spending in 2010, and are responsible for 7 of 10 deaths each year.
During Health 2.0's 10th annual conference, DrBonnie360 brings her unique, digital health and chronic disease insight to lead a panel of innovators leading in chronic disease management.
Companies of all shapes and sizes are driving business forward using policyIQ for automation and consolidation of GRC and other content. Contact us and have your site fully implemented for any one application 4-6 weeks from today!
April 18, 2018
Decision aids can be highly-effective tools to promote shared decision making and support patients in becoming engaged participants in their healthcare. Join us for the first-ever convening with leaders behind a Washington experiment in certifying decision aids, as state officials, health systems, and on-the-ground implementation experts share lessons learned and discuss policy recommendations for national or statewide approaches to decision aid certification.
For more information, visit our website at: http://petrieflom.law.harvard.edu/events/details/decision-aids-for-patients-with-serious-illness
Platforms for Chronic Disease Management at Health 2.0DrBonnie360
There are approximately 117M Americans living with chronic disease. Chronic medical conditions took 85% of all healthcare spending in 2010, and are responsible for 7 of 10 deaths each year.
During Health 2.0's 10th annual conference, DrBonnie360 brings her unique, digital health and chronic disease insight to lead a panel of innovators leading in chronic disease management.
Companies of all shapes and sizes are driving business forward using policyIQ for automation and consolidation of GRC and other content. Contact us and have your site fully implemented for any one application 4-6 weeks from today!
Двійкове кодування. Одиниці вимірювання довжини двійкового коду.
Практична робота 1. Розв‘язування задач на визначення довжини двійкового коду текстових даних
Урок 13 для 10 класу - Відкриття, створення та збереження презентацій. Практи...VsimPPT
Завантаження доступне на http://vsimppt.com.ua/
-------
Урок 13 для 10 класу - Відкриття, створення та збереження презентацій. Практична робота №4. Розробка слайдової презентації.
Research proposal focus cardiovascular and other disease biology - Pubrica ...Pubrica
• Heart failure (HF) stays a leading reason for morbidity and mortality, affecting 23 million human beings worldwide.
• In distinction to different types of cardiovascular conditions, its occurrence and mortality rates continue to increase.
• Almost 50% of sufferers with HF will die within 5 years of diagnosis, and up to 40% of sufferers die within 1 year of hospitalization.
To Visit For More Details, Click here:-https://bit.ly/2WV27ue
Why Pubrica?
When you order our services, we promise you the following – Plagiarism free, always on Time, outstanding customer support, written to Standard, Unlimited Revisions support and High-quality Subject Matter Experts.
Contact us :
Web: https://pubrica.com/
Blog: https://pubrica.com/academy/
Email: sales@pubrica.com
WhatsApp : +91 9884350006
United Kingdom: +44- 74248 10299
The Journal of General Medicine, India’s first on-line medical journal that promises to deliver both quality and varied content that would benefit ALL Doctors across specialties.
Presented by: Angela Greetham, Bay of Plenty DHB
at OHSIG 2014, Thursday 11/9/14, Limelight Room 1, 11.15am
Video URLs:
HQSC on fall prevention: www.youtube.com/watch?v=NdO7JCXJBO4
Examination of the incidence of heart disease in the US. A multivariate logis...AJHSSR Journal
ABSTRACT:Heart disease is a condition that affects the human heart and blood vessels. Heart disease affects
about half of American adults, and it also played a role in the high death rate in the rest of the world. The data
extracted from National Center for Health Statistics (NCHS) span from December 2019 to December 2021. The
only goal of this study is to look at the risk factors that affect the incidence of heart disease. After that, it will
estimate a Youden index to find the best cut-off point and measure how well the multivariate logistic regression
model's diagnostic test performed, adding to the body of knowledge. The application of logistic regression
yielded the finding that socioeconomic and health risk variables strongly influence the incidence of heart
disease. According to the Youden index, the ideal cutoff value is around 52%. Consequently, it is crucial for
American adults to monitor their lifestyle, have their BMI, blood pressure, diabetes, and other risk factors for
heart disease diagnosed, and then make sure they are receiving adequate treatment to prevent the tendency to
develop heart disease, which in turn will lower the death rate brought on by heart disease.
KEYWORDS: Heart disease, Multivariate logistic regression, Youden index, Health risk factors,
socioeconomic factors.
Self-Regulatory Model of Illness Perception .pptxanmolayaz
Leventhal's Self-Regulatory Model of Illness Perception includes:
Overview of Leventhal's Self-Regulatory Model of Illness Perception,
cognitive representation, emotional representation, and model application on breast cancer and lung cancer, coping strategies, techniques, and therapies for the self-regulation model, critique, and limitations
Health co morbidity effects on injury compensation claims in NZ, and evidence...John Wren
This PPT presents the results of a suite of research undertaken to explore the evidence for health comorbidity effects on the cost of injury compensation claims, and what might be done about them. Comorbidity effects were shown to add approximately 10% extra to the cost of claims. There is good evidence that workplace health and wellness programmes are effective if well designed
Care of Sickle Cell Disease Patients: Process Improvement & Change with NursesTosin Ola-Weissmann
Populations with SCD are at risk for disparities primarily because of the lack of knowledge on the part of the healthcare providers regarding the disease; inadequate pain management and prejudice among the staff (Tanabe & Myers, 2007).
On interviewing several nurses in the hospital, many acknowledge that they have never taken care of a patient with SCD and do not know what to assess for. The only nurse with experience of taking care of a SCD patient did not know the complications of the disease and wondered why sickle cell patients “always request pain medication when it’s obvious they are not in pain.”
This presentation is a guide providing essential information to medical professionals on dealing with patients that have sickle cell anemia. In addition, the SCD questionnaire is designed to enhance the assessment of SCD patients by medical professionals in the emergency room and serve as a platform for understanding their vulnerabilities during assessment.
Emphasis of this questionnaire is placed on identifying risk factors for depression, the patient’s socio-economic barriers, lifestyle habits, transportation issues, safe home environment, effective pain management and avenues for possible genetic counseling all of which sickle cell patients have shown vulnerability to (Dorsey & Murdaugh, 2003).
1. ALZHEIMER’S DISEASE:
MANAGEMENT CHALLENGES
& TREATMENT MEASURES
RICCI M. HAYES
JUNE 7, 2015
HCM310 – Introduction to the U.S. Healthcare System
Colorado State University – Global Campus
Dr. Dawn Tesner
2. Alzheimer’s Disease (AD): The Numbers
AD afflicts 5.2 million people and is
expected to reach as much as 16
million by 2050 (Medscape, 2015a).
Americans spend roughly
$100,000,000 per year on AD
care, a figure expected to rise
exponentially (de la Torre, 2010).
Source: http://reference.medscape.com/features/slideshow/alzheimers/
80-90% of nursing home patients
with dementia have
neuropsychiatric symptoms, a
precursor to staff turnover, stress,
and burnout (Van de Ven, Draskovic, Van
Herpen, Koopmans, Donders, Zuidema,
Adang, Vernooij-Dassen , 2014).
3. Incidence of AD vs other chronic disease
Aging-related Alzheimer’s Disease
increasingly evident until ~ 90
years old
Other co-morbidities such as
diabetes and arthritis, start to
decline ~ 70-80 years old.
(Akushevich, Kravchenko, Ukraintseva,
Arbeev, &Yashin, 2012).
Source: Akushevich, et al, 2012, p. 325
4. AD in Skilled Nursing Facilities (SNFs)
Many AD afflicted are in SNFs. This is covered
by Medicare, right?
Not exactly…
Days 1-20, paid in full
Days 21-100, Medicare Part A pays primary,
patient pays co-pay
Day 101…no Medicare reimbursement
(Center for Medicare & Medicaid Services, 2014)
5. Affordable Care Act (ACA) and AD
ACA includes mandate: improve transparency
about ownership of SNFs (Sultz & Young, 2014).
ACA through CMS provides patient
information about “grades” of SNFs relative to:
Health Inspection
Staffing
Quality Measures (Medicare, 2015)
6. AD Treatment & Cost Containment
Are there treatment options that reduce cost of
long-term care?
Van de Ven, et al, (2014) previously studied
dementia-care mapping (DCM) and showed
effective in dementia care, but sought to
examine further…
Is the one-to-one treatment cost efficient
for SNFs?
7. AD Treatment & Cost Containment (cont.)
“We find that DCM is a cost-neutral intervention
for nursing home residents with dementia that
has an advantage over usual care when it
comes to the costs of outpatient hospital
appointments. Since DCM has shown positive
effects on resident outcome measures such as
depression, agitation and quality of life,
considerations other than costs may
determine whether or not a nursing home will
adopt this method,” (Van de Ven, et al, 2014, p.8, para.2)
8. Prevention=Cost Savings Champion
There is no cure for Alzheimer’s.
Early prevention of known risk
factors, may delay, or even
eliminate the causation of AD.
Author states that “carotid artery
ultrasound and echocardiography
together with ankle-brachial index…
[are] cost-effective, non-invasive,
and reasonably accurate” in
detecting risks for AD (de la Torre,
2010, p.868, para.5).
Source: de la Torre. (2010). p.865
9. Prevention=Cost Savings Champion
In Medscape’s etiology section on AD, it says:
Midlife hypertension is an established risk factor for
late-life dementia, of which AD is the most common
type. A brain autopsy study evaluating the link
between hypertension and AD found that patients
using beta-blockers to control blood pressure had
fewer Alzheimer's-type brain lesions on autopsy
compared to patients taking no drug therapy or those
taking other medications (2015b).
10. Alzheimer’s Disease Management
AD is a debilitating, progressive disease.
AD care costs Americans millions of dollars.
AD has no cure.
Only by addressing the lifestyle, preventable
risks of AD, can we hope to curb the
increasing rate of disease and its associated
financial burden to American healthcare.
11. References
Akushevich, I., Kravchenko, J., Ukraintseva, S., Arbeev, K., Yashin, A. (2012, February). Age patterns of
incidence of geriatric disease in the U.S. elderly population: Medicare-based analysis. Journal of the
American Geriatrics Society, 60(2), 323-327. doi: 10.1111/j.1532-5415.2011.03786.x
Center for Medicare and Medicaid Services. (2014, August). Skilled nursing facility (SNF) billing reference.
Retrieved from http://www.cms.gov/Outreach-and-Education/Medicare-Learning-Network-
MLN/MLNProducts/downloads/SNFSpellIllnesschrt.pdf
de la Torre, J. (2010, July 1). Alzheimer’s disease is incurable but preventable. Journal of Alzheimer’s Disease,
20(3), 861-870. doi: 10.3233/JAD-2010-091579
Medicare. (2015). Nursing home compare. Retrieved from
http://www.medicare.gov/NursingHomeCompare/compare.html#cmprTab=0&cmprID=555161%2C05615
3%2C555639&cmprDist=0.7%2C1.0%2C3.6&loc=94558&lat=38.3170536&lng=-122.3019206
Medscape. (2015a). Alzheimer’s disease: Slideshow. Retrieved from
http://reference.medscape.com/features/slideshow/alzheimers/
Medscape. (2015b). Alzheimer disease: Etiology. Retrieved from
http://emedicine.medscape.com/article/1134817- overview#aw2aab6b2b5
Sultz, H. & Young, K. (2014). Health care USA: Understanding its organization and delivery (8th edition).
Burlington, MA: Jones & Bartlett Learning, LLC.
Van de Ven, G., Draskovic, I., Van Herpen, E., Koopmans, R., Donders, R., Zuidema, S., Adang, E., Vernooij-
Dassen, M. (2014, January). The economics of dementia-care mapping in nursing homes: A cluster-
randomised controlled trial. Plos One, 9(1), 1-8. doi: 10.1371/journal.pone.0086662
Editor's Notes
Comparison between healthy brain and one with AD shows the death of brain tissue. Critics of AD “treatment” say that even if you could re-grow neuropathways, they would not be that of the original being and are therefore, unethical (Akushevich, Kravchenko, Ukraintseva, Arbeev, Yashin, 2012).
Study from authors of Medicare data reviewing 26% of the U.S. population to evaluate the incidence of AD among population over 70 years of age. Interestingly, while AD incidence climbs to age 90-95, incidence of other chronic disease declines with age, making AD a greater concern for long term care facilities (LTCF).
Other provisions are supported by Affordable Care Act including respite care and in-home services (Sultz & Young, 2014). But for SNFs, billing management is imperative. AD afflicted will not be “cured” in 100 days.
I was surprised to find the ‘Nursing Home Compare’ link on CMS website. In the reference provided you will find three clinics with which I have regular contact. My assumption was that Meadows, a non-profit SNF would receive the top ranking; I was off-base.
Netherlands study involving 318 residents and 376 staff members. The question arose from their previous study; it’s one thing to identify effective measures in AD management, but quite another to consider whether treatments are indicated and efficient.
The study indicated that although no ‘savings’ were identified in the increased staff attention, neither were additional expenses identified; there were secondary cost savings, such as those with outpatient hospital appointments, needs for which were reduced.
Author is critical of “treatments” for AD suggesting that medications for removing plaques from what are really dead brain neurotransmitters, is like digging up graves and expecting people to rise from the dead. Prevention may not only be most effective for AD, but come at a great cost savings for future generations.
This information further illustrates a link between preventing risk factors and preventing AD.
Risks for AD are preventable, and should be addressed with those not yet showing symptoms according to de la Torre, 2010.